Malin Corporation | MLC - Operating Profit


Malin Corporation reported EUR-1.1M in Operating Profit for its fiscal semester ending in December of 2024.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
ALKERMES USD -48.28M 37.33M Mar/2026
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Eurofins Scientific SE EUR 391.3M 139.6M Dec/2025
Ionis Pharmaceuticals USD -118M 97M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Lonza CHF 673M 243M Jun/2025
Malin Corporation EUR -1.1M 400K Dec/2024
Moderna USD -1.39B 531M Mar/2026
Organon & Co USD 217M 171M Dec/2025
Ovoca Bio EUR -1.16M 4.48M Jun/2025
Revvity USD 82.77M 63.06M Mar/2026
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025